Evidence for an association with type 2 diabetes mellitus at the PPARG locus in a South Indian population

Metabolism: Clinical and Experimental

Volumn 59, Issue 4, 2010, Pages 457-462

  Vimaleswaran, Karani S ^a,b,c   Radha, Venkatesan ^a,b   Jayapriya, Munuguru Gopal ^a,b   Ghosh, Saurabh ^d   Majumder, Partha P ^d   Rao, M R Sathyanarayana ^e,f   Mohan, Viswanathan ^a,b  

^a MADRAS DIABETES RESEARCH FOUNDATION   (India)

^b Dr Mohan's Diabetes Specialities Centre   (India)

^c INSTITUTE OF METABOLIC SCIENCE   (United Kingdom)

^d INDIAN STATISTICAL INSTITUTE   (India)

^e JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH   (India)

^f INDIAN INSTITUTE OF SCIENCE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALANINE; HISTIDINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; PROLINE; TRANSCRIPTION FACTOR;

ADIPOGENESIS; ADULT; ARTICLE; CONTROLLED STUDY; GENE; GENE LOCUS; GENETIC LINKAGE; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; INDIA; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PPARG2 GENE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AGED; CHROMOSOME MAPPING; DIABETES MELLITUS, TYPE 2; GENOTYPE; HAPLOTYPES; HUMANS; INDIA; MIDDLE AGED; PPAR GAMMA;

EID: 77949459788     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.07.034     Document Type: Article

References (31)

1. Froguel P., and Vaxillaire M. Genetic factors in the pathogenesis of type 2 diabetes. In: Pickup J.C., and Williams G. (Eds). Textbook of diabetes (1996), Blackwell Scientific Publishers, Oxford 20.1-21.1
2. King H., Aubert R.E., and Herman W.H. Global burden of diabetes, 1995-2025-prevalence, numerical estimates and projections. Diabetes Care 21 (1998) 1414-1431
3. Mohan V. Why are Indians more prone to diabetes?. J Assoc Physicians India 52 (2004) 468-474
4. Chandalia M., Abate N., Garg A., Stray-Gundersen J., and Grundy S.M. Relationship between generalized and upper body obesity to insulin resistance in Asian Indian men. J Clin Endocrinol Metab 84 (1999) 2329-2335
5. Ramachandran A., Snehalatha C., Viswanathan V., Viswanathan M., and Haffner S.M. Risk of noninsulin dependent diabetes mellitus conferred by obesity and central adiposity in different ethnic groups: a comparative analysis between Asian Indians, Mexican Americans and whites. Diabetes Res Clin Pract 36 (1997) 121-125
6. Joshi S.R. Metabolic syndrome-emerging clusters of the Indian phenotype. J Assoc Physicians India 51 (2003) 445-446
7. McKeigue P.M., Pierpoint T., Ferrie J.E., and Marmot M.G. Relationship of glucose intolerance and hyperinsulinaemia to body fat pattern in South Asians and Europeans. Diabetologia 35 (1992) 785-791
8. Abate N., and Chandalia M. The impact of ethnicity on type 2 diabetes. J Diabetes Complications 17 (2003) 39-58
9. Zimmet P., Taylor R., Ram P., King H., Sloman G., Raper L.R., et al. Prevalence of diabetes and impaired glucose tolerance in the biracial (Melanesian and Indian) population of Fiji: a rural-urban comparison. Am J Epidemiol 118 (1983) 673-688
10. Mckeigue P.M., Miller G.J., and Marmot M.G. Coronary artery disease in South Asian overseas: a review. J Clin Epidemiol 41 (1989) 597-598
11. Mckeigue P.M. Coronary heart disease in Indians, Pakistanis and Bangladeshis: aetiology and possibilities for prevention. Br Heart J 67 (1992) 341-342
12. Semple R.K., Chatterjee V.K., and O'Rahilly S. PPARG and human metabolic disease. J Clin Invest 116 (2006) 581-589
13. Radha V., Vimaleswaran K.S., Deepa R., and Mohan V. The genetics of diabetes mellitus. Indian J Med Res 117 (2003) 225-238
14. Balasubramanyam M., and Mohan V. Current concepts of PPAR-gamma signaling in diabetes mellitus. Curr Sci 79 (2000) 1440-1446
15. Mudaliar S., and Henry R.R. PPAR agonists in health and disease: a pathophysiologic and clinical overview. Curr Opin Endocrinol Diabetes 9 (2002) 285-302
16. Berger J., Bailey P., Biswas C., Cullinan C.A., Doebber T.W., Hayes N.S., et al. Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice. Endocrinology 137 (1996) 4189-4195
17. Auwerx J. PPAR gamma, the ultimate thrifty gene. Diabetologia 42 (1999) 1033-1049
18. Radha V., Vimaleswaran K.S., Abate N., Chandalia M., Satjia P., Grundy S.M., et al. Role of genetic polymorphism PPAR-gamma Pro12Ala on ethnic susceptibility to diabetes of South Asians. Diabetes Care 29 (2006) 1046-1051
19. Vimaleswaran K.S., Radha V., Deepa R., and Mohan V. Absence of association of metabolic syndrome with PPARGC1A, PPARG and UCP1 gene polymorphisms in Asian Indians. Metab Syndr Relat Disord 5 (2007) 153-162
20. Deepa M., Pradeepa R., Rema M., Anjana M., Deepa R., Shanthirani S., et al. The Chennai Urban Rural Epidemiology Study (CURES)-study design and methodology (urban component) (CURES-1). J Assoc Physicians India 51 (2003) 863-870
21. Alberti K.G., and Zimmet P.Z. Definition diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus, provisional report of a WHO Consultation. Diabet Med 15 (1998) 539-553
22. Yen C.J., Beamer B.A., Negri C., Silver K., Brown K.A., Yarnall D.P., et al. Molecular scanning of the human peroxisome proliferator activated receptor gamma (hPPAR gamma) gene in diabetic Caucasians: identification of a Pro12Ala PPAR gamma 2 missense mutation. Biochem Biophys Res Commun 241 (1997) 270-274
23. Altshuler D., Hirschhorn J.N., Klannemark M., Lindgren C.M., Vohl M.C., Nemesh J., et al. The common PPAR gamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26 (2000) 76-80
24. Deeb S.S., Fajas L., Nemoto M., Pihlajamaki J., Mykkanen L., Kuusisto J., et al. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 20 (1998) 284-287
25. Meirhaeghe A., Fajas L., Helbecque N., Cottel D., Lebel P., Dallongeville J., et al. A genetic polymorphism of the peroxisome proliferator-activated receptor-gamma gene influences plasma leptin levels in obese humans. Hum Mol Genet 7 (1998) 435-440
26. Poulsen P., Andersen G., Fenger M., Hansen T., Echwald S.M., Volund A., et al. Impact of two common polymorphisms in the PPARgamma gene on glucose tolerance and plasma insulin profiles in monozygotic and dizygotic twins: thrifty genotype, thrifty phenotype, or both?. Diabetes 52 (2003) 194-198
27. Tavares V., Hirata R.D., Rodrigues A.C., Monte O., Salles J.E., Scallissi N., et al. Effect of the peroxisome proliferator-activated receptor-gamma C161T polymorphism on lipid profile in Brazilian patients with type 2 diabetes mellitus. J Endocrinol Invest 28 (2005) 129-136
28. Doney A., Fischer B., Frew D., Cumming A., Flavell D.M., World M., et al. Haplotype analysis of the PPAR gamma Pro12Ala and C1431T variants reveals opposing associations with body weight. BMC Genet 3 (2002) 21
29. Doney A.S., Fischer B., Cecil J.E., Boylan K., McGuigan F.E., Ralston S.H., et al. Association of the Pro12Ala and C1431T variants of PPARG and their haplotypes with susceptibility to Type 2 diabetes. Diabetologia 47 (2004) 555-558
30. Ristow M., Muller-Wieland D., Pfeiffer A., Krone W., and Kahn C.R. Obesity associated with a mutation in a genetic regulator of adipocyte differentiation. N Engl J Med 339 (1998) 953-959
31. Barroso I., Gurnell M., Crowley V.E., Agostini M., Schwabe J.W., Soos M.A., et al. Dominant negative mutations in human PPAR-gamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 402 (1999) 880-883